Nu-Med Plus (NUMD) Other financing activities (2017 - 2022)

Nu-Med Plus has disclosed Other financing activities across 6 years of filings, most recently posting $35000.0 for Q3 2022.

• Other financing activities for Q3 2022 came in at $35000.0, changed N/A year-over-year; the trailing twelve-month figure through Sep 2022 was $200760.0 (changed N/A YoY), and the FY2021 annual result was $200000.0, down 48.3% from the prior year.
• Other financing activities came in at $35000.0 for Q3 2022 at Nu-Med Plus, down from $50000.0 in the prior quarter.
• In the past five years, Other financing activities ranged from a high of $639000.0 in Q3 2018 to a low of $28260.0 in Q4 2020.
• The 5-year median for Other financing activities is $50000.0 (2018), against an average of $144213.3.
• Across the five-year window, Other financing activities slumped 92.18% in 2019 and surged 1122.3% in 2020, its largest moves.
• Nu-Med Plus' Other financing activities stood at $123863.0 in 2018, then slumped by 59.63% to $50000.0 in 2019, then slumped by 43.48% to $28260.0 in 2020, then soared by 76.93% to $50000.0 in 2021, then dropped by 30.0% to $35000.0 in 2022.
• The last three Other financing activities figures came in at $35000.0 (Q3 2022), $50000.0 (Q1 2021), and $28260.0 (Q4 2020), per Business Quant data.